Requested OTC NSAID Labeling Includes Cardiac Risk, Front Panel Changes
This article was originally published in The Tan Sheet
Executive Summary
Manufacturers of over-the-counter non-steroidal anti-inflammatory drugs should prominently identify their products as NSAIDs on packaging, according to an FDA request